生命倫理和法律
無輸血醫療策略的分配正義和成本效益
The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2017;153(3):597-605.e1.
檢索: PubMed 27938898
DOI碼: 10.1016/j.jtcvs.2016.10.083
Peri-operative blood transfusion increases length of hospital stay and number of postoperative complications in non-cardiac surgical patients. （開啟新視窗）
來源: Hong Kong Med J 2010;16(2):116-20.
檢索: PubMed 20354245
Justice and respect for autonomy: Jehovah's Witnesses and kidney transplant. （開啟新視窗）
來源: J Clin Ethics 2018;29(4):305-12.
檢索: PubMed 30605440
Implementing a health system-wide patient blood management program with a clinical community approach. （開啟新視窗）
來源: Anesthesiology 2017;127(5):754-64.
檢索: PubMed 28885446
DOI碼: 10.1097/ALN.0000000000001851
The ONTraC Ontario program in blood conservation. （開啟新視窗）
來源: Transfus Apher Sci 2014;50(1):32-6.
檢索: PubMed 24388485
DOI碼: 10.1016/j.transci.2013.12.010
Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. （開啟新視窗）
來源: Transfusion 2017;57(2):357-66.
檢索: PubMed 28019009
DOI碼: 10.1111/trf.13936
Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation. （開啟新視窗）
來源: Cost Eff Resour Alloc 2010;8(1):1.
檢索: PubMed 20163726
DOI碼: 10.1186/1478-7547-8-1
Patient Blood Management: improving outcomes for millions while saving billions. What is holding it up? （開啟新視窗）
來源: Anesth Analg 2022;135(3):511-23.
檢索: PubMed 35977361
DOI碼: 10.1213/ANE.0000000000006138
Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. （開啟新視窗）
來源: Anaesthesia 2019;74(12):1534-41.
檢索: PubMed 31448406
DOI碼: 10.1111/anae.14816
Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. （開啟新視窗）
來源: J Thorac Cardiovasc Surg 2013;145(3):796-804.
檢索: PubMed 23414992
DOI碼: 10.1016/j.jtcvs.2012.12.041
Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. （開啟新視窗）
來源: Transfusion 2017;57(6):1347-58.
檢索: PubMed 28150313
DOI碼: 10.1111/trf.14006
Clinical outcomes, blood utilization, and ethical considerations for pediatric patients in a bloodless medicine and surgery program. （開啟新視窗）
來源: Anesth Analg 2024;138(2):465-74.
檢索: PubMed 38175737
DOI碼: 10.1213/ANE.0000000000006776
Safety, cost savings, simplicity back broader use of bloodless surgery. （開啟新視窗）
來源: OR Manager 2013;29(5):1, 6, 8-9.
檢索: PubMed 23755462
Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome: a prospective, multicenter cohort study with a noninferiority design. （開啟新視窗）
來源: Ann Surg 2016;264(2):203-11.
檢索: PubMed 27163948
DOI碼: 10.1097/SLA.0000000000001747
ONTraC: A 20-year history of a successfully coordinated provincewide Patient Blood Management Program: lessons learned and goals achieved. （開啟新視窗）
來源: Anesth Analg 2022;135(3):448-58.
檢索: PubMed 35977355
DOI碼: 10.1213/ANE.0000000000006065
Effective reduction of blood product use in a community teaching hospital: when less is more. （開啟新視窗）
來源: Am J Med 2013;126(10):894-902.
檢索: PubMed 24054957
DOI碼: 10.1016/j.amjmed.2013.06.013
Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. （開啟新視窗）
來源: BMC Health Serv Res 2011;11:135.
檢索: PubMed 21627788
DOI碼: 10.1186/1472-6963-11-135
Increased hospital costs associated with red blood cell transfusion. （開啟新視窗）
來源: Transfusion 2015;55(5):1082-9.
檢索: PubMed 25488623
DOI碼: 10.1111/trf.12958
An economic analysis of costs associated with development of a cell salvage program. （開啟新視窗）
來源: Anesth Analg 2007;104(4):869-75.
檢索: PubMed 17377098
DOI碼: 10.1213/01.ane.0000258039.79028.7c